Modelling the impact of compliance on the costs and effects of long-acting risperidone in Canada
Modelling the impact of compliance on the costs and effects of long-acting risperidone in Canada
About this item
Full title
Author / Creator
Publisher
New Zealand
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand
Subjects
More information
Scope and Contents
Contents
Schizophrenia is a chronic, relapsing disease that requires more healthcare resources to manage than any other single psychiatric illness. The main cost of treatment is hospitalization as a result of the exacerbation of symptoms often caused by poor compliance. Although the costs of hospitalization and relapse have been well documented, the differe...
Alternative Titles
Full title
Modelling the impact of compliance on the costs and effects of long-acting risperidone in Canada
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_69073679
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_69073679
Other Identifiers
ISSN
1170-7690
E-ISSN
1179-2027
DOI
10.2165/00019053-200523001-00006
